Table 5.
HF Stage † | Hazards Ratios for Events (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|
Clinical HF Events* | CVD Events* | CVD Death* | All‐Cause Death* | |||||
Age ≤ Median (130/708) | Age ˃Median (152/913) | Age ≤ Median (201/760) | Age ˃Median (160/949) | Age ≤ Median (122/807) | Age ˃Median (58/975) | Age ≤ Median (376/807) | Age ˃Median (222/975) | |
A | Referent | Referent | Referent | Referent | Referent | Referent | Referent | Referent |
B | 1.9 (1.2–3.1) | 1.6 (1.1–2.5) | 1.4 (0.9–2.1) | 1.5 (1.0–2.3) | 2.2 (1.2–4.1) | 1.8 (0.9–3.9) | 1.6 (1.2–2.2) | 1.3 (0.9–1.9) |
C/D | … | … | 3.0 (1.9–5.0) | 1.7 (0.8–3.6) | 7.4 (3.7–14.7) | 7.0 (2.8–17.5) | 3.5 (2.4–5.0) | 2.9 (1.8–4.7) |
P for interaction ‡ | 0.63 | 0.21 | 0.21 | 0.59 |
CVD indicates cardiovascular disease; HF, heart failure; and MI, myocardial infarction.
We provide the number of events for each outcome within each age category and the total number of participants.
HF stage A formed the referent group in all tests. We excluded prevalent MI in heart stage B (N=89).
P value for interaction of HF stage with median age.